PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: General Electric Company

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GE’s Latest Radiotherapy Simulation CT Systems Target Cancer - Recently cleared by the FDA, GE’s wide-bore RT imaging systems deliver diagnostic accuracy, increased productivity, and are designed with treatment planning in mind (NYSE: GE) -
GE’s Latest Radiotherapy Simulation CT Systems Target Cancer


NewswireToday - /newswire/ - Waukesha, WI, United States, 2011/08/01 - Recently cleared by the FDA, GE’s wide-bore RT imaging systems deliver diagnostic accuracy, increased productivity, and are designed with treatment planning in mind (NYSE: GE) - NYSE: GE

Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


As the 2011 American Association of Physicists in Medicine (AAPM) and Canadian Organization of Medical Physicists (COMP) joint meeting opens today in Vancouver, Canada, GE Healthcare announced the recent FDA clearance and increasing global utilization of its new platform of Radiotherapy (RT) Planning Computed Tomography (CT) systems. Highlighted by the Discovery* CT590 RT, these cutting-edge CT systems are designed specifically with treatment planning in mind and help physicians address the increasingly specialized imaging needs of patients.

GE’s new wide bore RT portfolio – including the Discovery CT590 RT and Optima* CT580 RT – is dedicated to meeting both current and future clinical oncology demands for diagnostic accuracy, enhanced visualization, complex patient positioning and monitoring, and productive workflow.

“This new RT platform represents yet another step toward more patient-centered, user-friendly medical imaging for oncology,” said Scott Schubert, General Manager for GE Healthcare’s Premium CT Product Marketing. “Designed to offer enhancements in precision and workflow while delivering accurate image detail, these systems are ultimately about helping physicians deliver high quality cancer treatment across the entire therapy process.”

Built from the ground up and flexible in a variety of radiation oncology settings, the new RT systems are powered by the latest in GE CT technology. For example, the Discovery CT590 RT offers an automated 4D video organ motion recording feature which captures organ movement to better adapt future radiation therapy treatments.

“As new treatment technologies emerge in radiotherapy, there is an increasing need for intuitive imaging systems supported by robust clinical applications and reliable service,” said Randy Hemingway, Administrative Director of Radiation Oncology at Washington Hospital Center in Washington, D.C. “Our new Discovery CT590 RT with Advantage 4D and Advantage SimMD offer just such benefits – helping us improve workflow with accuracy as we seek optimal clinical outcomes that best meet our patients’ needs.”

In addition to imaging for oncology, this new family of RT products will also be available for interventional and bariatric CT. In fact, the Discovery CT590 RT can leverage GE’s leading dose reduction technology called ASiR* (Adaptive Statistical Iterative Reconstruction). This reconstruction technology may enable reduction in pixel noise standard deviation and improvement in low contrast detectability, and may allow for reduced mA in the acquisition of diagnostic images, thereby reducing the dose required.+

“For clinicians and physicians, clear visualization and low contrast detectability are important for effective treatment,” noted Schubert. “This new RT platform leverages GE’s advanced CT technology and image quality for the demanding clinical needs in radiation therapy, bariatric surgery and interventional programs – all in an effort to enhance workflow and help physicians best serve patients.”

* Trademark of General Electric Company

+ In clinical practice, the use of ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.

About GE Healthcare
GE Healthcare ( provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

For our latest news, please visit

Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: General Electric Company


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!

GE’s Latest Radiotherapy Simulation CT Systems Target Cancer

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

GE News Center |
Publisher Contact: Benjamin Fox - GE Healthcare 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any General Electric Company securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From General Electric Company / Company Profile

Read Health/Surgery Most Recent Related Newswires:

The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus
Apollo eDoc Launched Online Appointment Platform
Digital Health and Point of Care Driving Growth Opportunities in the Rise of Mobile Molecular Diagnostics Says Frost & Sullivan
New Veterinarian Joins DPC Veterinary Hospital in Davie
Aggressive Expansion and Consolidation Strategies Define APAC’s Top Fifty Healthcare Services Companies Finds Frost & Sullivan
Frost & Sullivan Lauds VitreosHealth’s Advanced Predictive Analytics Solution for Providing Accurate Predictive Risk Analyses of a Population’s Health
Breakthrough Coaching Gung-ho About New Alliance Partner Zingit Solutions

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  MagLar, Inc.


  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (